公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 LABTEST DIAGNOSTICA S/A取消

45 记录

产品持有公司班级有效性
AFP Reagent Kit10009010425LABTEST DIAGNOSTICA S/AIII15/01/2034
Anti SARS-CoV-2 & M. pneumoniae IgG/IgM Rapid Test Combo10009010373LABTEST DIAGNOSTICA S/AIII14/06/2031
Anti SARS-CoV-2 IgM/IgG Rapid Test10009010360LABTEST DIAGNOSTICA S/AIII08/09/2030
Anti SARS-CoV-2 IgM/IgG Rapid Test SD10009010364LABTEST DIAGNOSTICA S/AIII12/11/2030
Anti-Dengue IgG Reagent Kit10009010512LABTEST DIAGNOSTICA S/AIII24/08/2036
Anti-Dengue IgM Reagent Kit10009010508LABTEST DIAGNOSTICA S/AIII22/06/2036
Anti-HAV IgG Reagent Kit10009010496LABTEST DIAGNOSTICA S/AIII14/07/2035
Anti-HAV IgM Reagent Kit10009010503LABTEST DIAGNOSTICA S/AIII15/09/2035
CA 125 Reagent Kit10009010464LABTEST DIAGNOSTICA S/AIII21/10/2034
CA 15-3 Reagent Kit10009010473LABTEST DIAGNOSTICA S/AIII21/10/2034
CA 19-9 Reagent Kit10009010465LABTEST DIAGNOSTICA S/AIII21/10/2034
CEA Reagent Kit10009010466LABTEST DIAGNOSTICA S/AIII21/10/2034
CK-MB LIQUIFORM10009010069LABTEST DIAGNOSTICA S/AIII01/03/2035
COVID-19 & FLU A/B Ag Rapid Test Combo10009010372LABTEST DIAGNOSTICA S/AIII14/06/2031
COVID-19 Ag Rapid Test10009010361LABTEST DIAGNOSTICA S/AIII24/09/2030
COVID-19 Ag Rapid Test (Swab Naso/Oro)10009010374LABTEST DIAGNOSTICA S/AIII21/06/2031
Covid-19 Ag Rapid Test (Oral Fluid)10009010371LABTEST DIAGNOSTICA S/AIII31/05/2031
Cyfra 21-1 Reagent Kit10009010477LABTEST DIAGNOSTICA S/AIII21/10/2034
DETECT SARS-CoV-2 RT-PCR10009010357LABTEST DIAGNOSTICA S/AIII27/04/2030
Dengue Combo Rapid Test10009010488LABTEST DIAGNOSTICA S/AIII28/04/2035
Dengue IgG/IgM Rapid Test10009010489LABTEST DIAGNOSTICA S/AIII28/04/2035
Dengue NS1 Ag Reagent Kit10009010506LABTEST DIAGNOSTICA S/AIII26/01/2036
Detect SARS-CoV-2 (RT-PCR) Fast10009010377LABTEST DIAGNOSTICA S/AIII16/08/2031
Família Calibrador e Controles CK-NAC/CK-MB10009010511LABTEST DIAGNOSTICA S/AIII27/07/2036
Família Qualitrol Hemostasis10009010317LABTEST DIAGNOSTICA S/AIII21/09/2035

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家